Constellium SE (CSTM) - What Are Investment Firms Thinking About This Stock?

Key Points

• Analyst sentiment is moderately positive: Five of eight firms rate Constellium a buy and three rate it hold, with an average one-year price target of $33.29. Some firms recently cut their price targets or downgraded ratings.
• Quarterly results topped expectations: Constellium reported earnings of $0.84 per share versus a $0.73 estimate, and revenue of $2.64 billion versus a $2.50 billion estimate; revenue rose 21.8% year over year.
• A company director bought 1,800 shares at an average price of $23.41, while institutional investors collectively hold 92.59% of the stock.

Shares of Constellium SE (NYSE:CSTM - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eight research firms that are currently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $33.29.

Several brokerages have issued reports on CSTM. Zacks Research lowered Constellium from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, October 6th. Wall Street Zen downgraded shares of Constellium from a "strong-buy" rating to a "buy" rating in a research note on Saturday, October 17th. Weiss Ratings restated a "hold (c+)" rating on shares of Constellium in a research report on Monday, September 28th. Deutsche Bank Aktiengesellschaft reduced their price objective on Constellium from $39.00 to $36.00 and set a "buy" rating on the stock in a research note on Thursday, October 8th. Finally, Wells Fargo & Company reduced their price objective on Constellium from $38.00 to $33.00 and set an "overweight" rating on the stock in a research note on Thursday, October 29th.

Constellium Stock Down 0.1%

Shares of NYSE CSTM opened at $21.79 on Monday. The firm has a market cap of $2.93 billion, a PE ratio of 5.32 and a beta of 1.63. The company's fifty day simple moving average is $25.07 and its 200 day simple moving average is $27.84. The company has a quick ratio of 0.57, a current ratio of 1.48 and a debt-to-equity ratio of 1.33. Constellium has a 12-month low of $14.62 and a 12-month high of $36.99.

Constellium (NYSE:CSTM - Get Free Report) last posted its earnings results on Wednesday, October 28th. The industrial products company reported $0.84 EPS for the quarter, topping the consensus estimate of $0.73 by $0.11. The firm had revenue of $2.64 billion for the quarter, compared to analysts' expectations of $2.50 billion. Constellium had a net margin of 5.73% and a return on equity of 49.04%. The company's quarterly revenue was up 21.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.62 EPS. As a group, sell-side analysts forecast that Constellium will post 3.78 earnings per share for the current fiscal year.

Insider Transactions at Constellium

In other Constellium news, Director Jean-Christophe Deslarzes acquired 1,800 shares of the business's stock in a transaction on Monday, November 2nd. The shares were acquired at an average price of $23.41 per share, for a total transaction of $42,138.00. Following the completion of the acquisition, the director owned 45,315 shares in the company, valued at $1,060,824.15. This trade represents a 4.14% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.20% of the company's stock.

Institutional Trading of Constellium

A number of hedge funds have recently bought and sold shares of CSTM. Arrowstreet Capital Limited Partnership boosted its stake in Constellium by 620.9% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 3,228,027 shares of the industrial products company's stock worth $79,345,000 after purchasing an additional 2,780,260 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of Constellium by 894.4% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,056,336 shares of the industrial products company's stock valued at $50,545,000 after buying an additional 1,849,554 shares during the last quarter. Bank of America Corp DE lifted its stake in shares of Constellium by 100.1% in the first quarter. Bank of America Corp DE now owns 851,222 shares of the industrial products company's stock worth $20,923,000 after buying an additional 425,871 shares in the last quarter. Penn Capital Management Company LLC lifted its stake in shares of Constellium by 4.4% in the third quarter. Penn Capital Management Company LLC now owns 782,628 shares of the industrial products company's stock worth $18,966,000 after buying an additional 32,983 shares in the last quarter. Finally, Janus Henderson Group PLC lifted its stake in shares of Constellium by 775.9% in the first quarter. Janus Henderson Group PLC now owns 439,301 shares of the industrial products company's stock worth $10,797,000 after buying an additional 389,147 shares in the last quarter. Hedge funds and other institutional investors own 92.59% of the company's stock.

About Constellium

Constellium SE is a global manufacturer of aluminum products and solutions, serving customers in the aerospace, automotive, packaging, defense and industrial markets. Its offerings include rolled and extruded aluminum products, automotive structures and other engineered components.

The company operates through businesses focused on aerospace and transportation, packaging and automotive rolled products, and automotive structures and industry. Its products are used in applications such as aircraft, vehicles, beverage packaging and industrial equipment.

Constellium was established in 2011 from aluminum businesses with roots in Alcan and Pechiney.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.